Vanderbilt TB Center News

Publication Announcement: “Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis"

The U.S. Centers for Disease Control and Prevention (CDC) Tuberculosis Trials Consortium (TBTC), together with collaborators from the National Institutes of Health’s (NIH) AIDS Clinical Trial Group (ACTG), is pleased to announce the publication of “Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis" in the New England Journal of Medicine.

#LightUpforTB - The Korean War Veterans Memorial Bridge will turn RED!

The Metro Public Health Department (MPHD) is marking World TB Day on March 24 by lighting the Korean War Veterans Memorial Bridge RED, highlighting identification and treatment efforts to end Tuberculosis. Don't forget to drive by the bridge on March 24! See The Press Release here!

Vanderbilt TB Center FY 2020 Annual Report has been released!

The TB Center Annual Report from FY 2020 has now been published, detailing Center activities, research, and funding for the 2020 fiscal year. See the link below to download the full report. We look forward to continued progress toward our research goals in the current year.

Landmark TB Trial Identifies Shorter-Course Treatment Regimen

Results from Study 31/A5349 were presented today at the Union World Conference on Lung Health. This study was conducted internationally through the Tuberculosis Trials Consortium (TBTC) and the AIDS Clinical Trials Group (ACTG) with funding from the CDC and NIH. Vanderbilt University Medical Center/Nashville Metro Public Health is a participating TBTC site, though did not enroll patients into this trial. April Pettit, VUMC faculty member, was a member of the protocol team. From the CDC Press Release:

Vanderbilt TB Center FY 2019 Annual Report has been released!

The TB Center Annual Report from FY 2019 has now been published, detailing Center activities, research, and funding for the 2019 fiscal year. See the link below to download the full report. We look forward to continued progress toward our research goals in the current year.

Dr. Timothy Sterling featured on Occupational Health's Wellcast podcast, discussing latent TB infection

Dr. Timothy Sterling recently participated in Occupational Health's Wellcast podcast, discussing "What is Latent TB Infection?" During the podcast, Dr. Sterling discusses what is LTBI, diagnostic tests for LTBI, treatment options and why it's important to get treated. The Occupational Health Clinic performs a lot of TB testing for VUMC employees, and we hope this information is relevant to those wanting to know more about latent TB infection.